Non-muscle Invasive Bladder Cancer Market

Non-Muscle Invasive Bladder Cancer (NMIBC) is a common, heterogeneous disease confined to the bladder’s inner lining, sparing the muscle layer. It accounts for 70–80% of newly diagnosed bladder cancers, including non-invasive papillary tumors (pTa), carcinoma in situ (CIS; pTis), and early invasive tumors (pT1). NMIBC has high recurrence rates of 50–70%, though only 10–20% progress to muscle-invasive bladder cancer (MIBC), necessitating ongoing, long-term surveillance.

Download the full infographic to uncover detailed insights: https://www.delveinsight.com/infographics/non-muscle-invasive-bladder-cancer-market?utm_source=infographics&utm_medium=promotion&utm_campaign=akpr